Venkatakrishnan, K., Gupta, N., Smith, P. F., Lin, T., Lineberry, N., Ishida, T., . . . Rogge, M. (2023). Asia‐Inclusive Clinical Research and Development Enabled by Translational Science and Quantitative Clinical Pharmacology: Toward a Culture That Challenges the Status Quo. Clinical pharmacology and therapeutics, 113(2), 298-309. https://doi.org/10.1002/cpt.2591
Chicago Style (17th ed.) CitationVenkatakrishnan, Karthik, Neeraj Gupta, Patrick F. Smith, Tiffany Lin, Neil Lineberry, Tatiana Ishida, Lin Wang, and Mark Rogge. "Asia‐Inclusive Clinical Research and Development Enabled by Translational Science and Quantitative Clinical Pharmacology: Toward a Culture That Challenges the Status Quo." Clinical Pharmacology and Therapeutics 113, no. 2 (2023): 298-309. https://doi.org/10.1002/cpt.2591.
MLA (9th ed.) CitationVenkatakrishnan, Karthik, et al. "Asia‐Inclusive Clinical Research and Development Enabled by Translational Science and Quantitative Clinical Pharmacology: Toward a Culture That Challenges the Status Quo." Clinical Pharmacology and Therapeutics, vol. 113, no. 2, 2023, pp. 298-309, https://doi.org/10.1002/cpt.2591.